OutSee
The AI engine Fit Assessment
BetaOutSee leverages machine learning for genomic data analysis, discovering patterns and expanding therapeutic approaches in drug development.
Blurb
OutSee creates cutting-edge computational methods for genomics for the development of therapeutic targets and precision medicine.
HQ Location
United Kingdom
Founded
2022
Employees
1 - 10
Total funding raised
Not available
Last Funding Event
Not available
Smart insights
- Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
- Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
- 6m headcount growth: 25%
- 1Y headcount growth: 94%
- Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
- Genomic Data Analysis
Developer of an AI genomics technology designed to analyze genetic data for novel discoveries in drug development and precision medicine. The company's technology helps in standard analysis methods to identify potential causal mechanisms in diseases, approaches to identify causes of disease and inform drug discovery efforts, even with datasets previously analyzed by other methods, enabling researchers to get additional insights from existing genetic datasets.